Genenta Science S.p.A.(GNTA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

GNTA Genenta Science S.p.A.

Post-Market Trading 03-31 16:13:49 EDT

3.97

+0.00

0.00%

盘后3.85

-0.12-3.02%

16:01 EDT

High4.15	Low3.97	Vol7.98K
Open4.07	D1 Closing3.97	Amplitude4.53%
Mkt Cap72.61M	Tradable Cap44.57M	Total Shares18.29M
T/O31.75K	T/O Rate0.07%	Tradable Shares11.23M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Invest in Global Markets with Tiger Brokers!

Open App

{"stockData":{"symbol":"GNTA","market":"US","secType":"STK","nameCN":"Genenta Science S.p.A.","latestPrice":3.97,"timestamp":1743451200000,"preClose":3.97,"halted":0,"volume":7980,"hourTrading":{"tag":"盘后","latestPrice":3.85,"preClose":3.97,"latestTime":"16:01 EDT","volume":909,"amount":3514.8200283,"timestamp":1743451282570},"delay":0,"floatShares":11226473,"shares":18289866,"eps":-0.524354,"marketStatus":"Post-Market Trading","change":0,"latestTime":"03-31 16:13:49 EDT","open":4.07,"high":4.15,"low":3.97,"amount":31749.0392,"amplitude":0.04534,"askPrice":5.93,"askSize":25,"bidPrice":3.35,"bidSize":13,"shortable":3,"etf":0,"ttmEps":-0.524354,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1743465600000},"marketStatusCode":4,"adr":0,"adrRate":1,"listingDate":1639544400000,"exchange":"NASDAQ","adjPreClose":3.97,"postHourTrading":{"tag":"盘后","latestPrice":3.85,"preClose":3.97,"latestTime":"16:01 EDT","volume":909,"amount":3514.8200283,"timestamp":1743451282570},"volumeRatio":2.911134},"requestUrl":"/m/hq/s/GNTA","defaultTab":"news","newsList":[{"id":"2520913268","title":"Genenta Science Obtains $21.9 Million Financing to Expand Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2520913268","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520913268?lang=en_us&edition=full_marsco","pubTime":"2025-03-19 22:37","pubTimestamp":1742395072,"startTime":"0","endTime":"0","summary":"Genenta Science  said Wednesday it has obtained a 20 million euro  financing via the issuance of a mandatory convertible bond to ENEA Tech and Biomedical, or ETB, to advance temferon in metastatic renal cell cancer.ETB is a private foundation supervised by Italy's Ministry of Enterprises, the company said.Genenta Chief Executive Pierluigi Paracchi said the bond's conversion to equity is set for March 2028, followed by a lock-up period of two years.The company said a phase 1/2a trial in metastatic renal cell carcinoma has started enrolling patients.Genenta also said the February data cutoff from a phase 1/2a glioblastoma multiforme trial showed \"an increase in the percentage of patients surviving at two years,\" rising to 29% from 25% in October.Price: 3.71, Change: -0.08, Percent Change: -2.11","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["GNTA","BK4139"],"gpt_icon":0},{"id":"2514095452","title":"Top Premarket Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2514095452","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514095452?lang=en_us&edition=full_marsco","pubTime":"2025-02-25 20:36","pubTimestamp":1740487017,"startTime":"0","endTime":"0","summary":"Wah Fu Education Group  shares soared 82% pre-bell Tuesday after the company said it integrated DeepSeek into its learning programs.Landmark Bancorp  shares increased 32% following a 2.7% loss on Monday.Tandy Leather Factory  stock advanced 31% after Monday's 2.6% loss.Mannatech  shares surged 29% following a muted session.Genenta Science  shares were up 16% after a 1.8% loss on Monday.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4183","MTEX","BK4563","BK4204","BK4094","BK4211","WAFU","LARK","BK4506","BK4139","GNTA","TLF"],"gpt_icon":0},{"id":"2511646645","title":"Is Genenta Science S.p.A. (GNTA) the Best Italian Stock to Buy in 2025?","url":"https://stock-news.laohu8.com/highlight/detail?id=2511646645","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511646645?lang=en_us&edition=full_marsco","pubTime":"2025-02-13 13:03","pubTimestamp":1739423003,"startTime":"0","endTime":"0","summary":"We recently published a list of 12 Best Italian Stocks to Buy in 2025. In this article, we are going to take a look at where Genenta Science S.p.A. stands against other best Italian stocks to buy in 2025.As per Deloitte, the broader Italian economy slowed down in 2024, with moderate growth. The service sector expansion was contrasted with continued weakness in essentially all other sectors, mainly in manufacturing and automotive. The consumer and business sentiments in Italy were low across 2024, in the context of weakness in the critical economies of the euro area too.On the supply side, the broader GDP growth was only supported by the services sector in 2024, while essentially all other sectors witnessed a decline. With these impacts now behind us, what lies ahead for the broader Italian economy?Inflation Is Expected to Remain Moderate, Says Deloitte. Moving forward, Allianz Trade sees private consumption picking up due to a recovery in income and an easing of monetary policy. Notabl","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/genenta-science-p-gnta-best-050323457.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["QID","NVIW.SI","TSYW.SI",".IXIC","TQQQ","MNQmain","QQQ","SQQQ","USAW.SI","QLD","PSQ","BK4139","NQmain","USJW.SI","GNTA","CDMO"],"gpt_icon":0},{"id":"2503165213","title":"3 Penny Stocks In US With Market Caps Below $300M","url":"https://stock-news.laohu8.com/highlight/detail?id=2503165213","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503165213?lang=en_us&edition=full_marsco","pubTime":"2025-01-13 08:10","pubTimestamp":1736727003,"startTime":"0","endTime":"0","summary":"As the U.S. stock market faces a challenging period with major indexes declining for the second consecutive week, investors are navigating an environment shaped by rising Treasury yields and robust economic data. Amidst this backdrop, penny stocks—despite their somewhat outdated moniker—remain a relevant area of interest for those seeking unique investment opportunities. These smaller or newer companies can offer growth potential at lower price points, especially when they possess strong financials and solid fundamentals.Underneath we present a selection of stocks filtered out by our screen.Overview: Genenta Science S.p.A. is a clinical-stage biotechnology company focused on developing hematopoietic stem cell gene therapies for treating solid tumors in Italy, with a market cap of $86.88 million.Overview: Tiziana Life Sciences Ltd is a biotechnology company that focuses on discovering and developing molecules to treat human diseases in oncology and immunology in the United States, with ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/3-penny-stocks-us-market-001003762.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TLSA","PERF","BABB","BK4209","GNTA","BK4023"],"gpt_icon":0},{"id":"2502029731","title":"Genenta Science Says Enhanced Partnership With AGC Biologics to Boost Cell Therapy Manufacturing","url":"https://stock-news.laohu8.com/highlight/detail?id=2502029731","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502029731?lang=en_us&edition=full_marsco","pubTime":"2025-01-10 04:03","pubTimestamp":1736452981,"startTime":"0","endTime":"0","summary":"Genenta Science (GNTA) on Thursday said it enhanced its partnership with AGC Biologics.The partnership will help boost production capabilities, potentially improving efficiency and reliability in cell therapy product manufacturing, the company said.Price: 5.09, Change: +0.19, Percent Change: +3.88","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","GNTA"],"gpt_icon":0},{"id":"2502015383","title":"Genenta Science announces amendment to pact with AGC Biologics","url":"https://stock-news.laohu8.com/highlight/detail?id=2502015383","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502015383?lang=en_us&edition=full_marsco","pubTime":"2025-01-09 19:51","pubTimestamp":1736423503,"startTime":"0","endTime":"0","summary":"Genenta Science (GNTA) announced that it has strengthened its partnership with contract development and manufacturing organization AGC Biologics by...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/genenta-science-announces-amendment-to-pact-with-agc-biologics?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/genenta-science-announces-amendment-to-pact-with-agc-biologics?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GNTA","BK4139"],"gpt_icon":0},{"id":"2502972510","title":"Genenta Strengthens Agreement with AGC Biologics to Boost Cell Therapy Manufacturing","url":"https://stock-news.laohu8.com/highlight/detail?id=2502972510","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502972510?lang=en_us&edition=full_marsco","pubTime":"2025-01-09 19:00","pubTimestamp":1736420400,"startTime":"0","endTime":"0","summary":"Sharing Insights at the 'Italy on the Move' Event and Engaging Investors at Biotech Showcase During JPM Healthcare Week in San FranciscoMILAN and NEW YORK, Jan.  09, 2025  (GLOBE NEWSWIRE) -- Genenta ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/01/09/3006902/0/en/Genenta-Strengthens-Agreement-with-AGC-Biologics-to-Boost-Cell-Therapy-Manufacturing.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GNTA","BK4139","CDMO"],"gpt_icon":0},{"id":"2487550666","title":"Genenta Science SPA (ADR) trading halted, volatility trading pause","url":"https://stock-news.laohu8.com/highlight/detail?id=2487550666","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2487550666?lang=en_us&edition=full_marsco","pubTime":"2024-11-29 22:35","pubTimestamp":1732890920,"startTime":"0","endTime":"0","summary":"09:30 EST Genenta Science (GNTA) SPA (ADR) trading halted, volatility trading pause Published first on TheFly – the ultimate source for real-time, ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/genenta-science-spa-adr-trading-halted-volatility-trading-pause-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/genenta-science-spa-adr-trading-halted-volatility-trading-pause-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GNTA","BK4139","SPA"],"gpt_icon":0},{"id":"2483378238","title":"3 US Penny Stocks With Market Caps Over $30M To Consider","url":"https://stock-news.laohu8.com/highlight/detail?id=2483378238","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483378238?lang=en_us&edition=full_marsco","pubTime":"2024-11-14 01:05","pubTimestamp":1731517511,"startTime":"0","endTime":"0","summary":"The U.S. stock market has recently shown resilience, with the Dow Jones and S&P 500 inching higher following a benign CPI inflation reading. In this context, investors might find value in exploring penny stocks, which despite their somewhat outdated moniker, continue to offer intriguing opportunities for growth. These typically smaller or newer companies can present a blend of affordability and potential when backed by strong financials.Click here to see the full list of 739 stocks from our US Penny Stocks screener.Overview: Genenta Science S.p.A. is a clinical-stage biotechnology company focused on developing hematopoietic stem cell gene therapies for treating solid tumors in Italy, with a market cap of $88.83 million.Overview: NetSol Technologies, Inc. specializes in creating and distributing enterprise software solutions for the automobile financing and leasing, banking, and financial services sectors across the United States, North America, Europe, and Asia Pacific with a market ca","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/fZxxC7WFAddugsI0.C6IZw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/2b615bb0216a492e754128412857f305","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/fZxxC7WFAddugsI0.C6IZw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/2b615bb0216a492e754128412857f305"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/3-us-penny-stocks-market-170511046.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4209","BK4563","BK4551","PHX","BABB","NTWK","ASFH","BK4526","KVHI","BK4139","BK4213","BK4009","GNTA","RLX","BK4075"],"gpt_icon":0},{"id":"2477588979","title":"Genenta’s CEO to present at the U.S. Senate meeting on “Cross-Border Investments and Strategies in the Biotechnology Sector: A Transatlantic Perspective”","url":"https://stock-news.laohu8.com/highlight/detail?id=2477588979","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477588979?lang=en_us&edition=full_marsco","pubTime":"2024-10-23 19:00","pubTimestamp":1729681200,"startTime":"0","endTime":"0","summary":"MILAN and NEW YORK, Oct.  23, 2024  (GLOBE NEWSWIRE) -- Genenta Science (NASDAQ: GNTA), a pioneer in immuno-oncology and in cell-based therapeutics, is pleased to announce that Pierluigi Paracchi, CEO","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/10/23/2967634/0/en/Genenta-s-CEO-to-present-at-the-U-S-Senate-meeting-on-Cross-Border-Investments-and-Strategies-in-the-Biotechnology-Sector-A-Transatlantic-Perspective.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TAT","BK4139","GNTA"],"gpt_icon":0},{"id":"2477986110","title":"Genenta Science SPA (ADR) trading resumes","url":"https://stock-news.laohu8.com/highlight/detail?id=2477986110","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477986110?lang=en_us&edition=full_marsco","pubTime":"2024-10-21 22:17","pubTimestamp":1729520226,"startTime":"0","endTime":"0","summary":"09:35 EDT Genenta Science (GNTA) SPA (ADR) trading resumes Published first on TheFly – the ultimate source for real-time, market-moving breaking fi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/genenta-science-spa-adr-trading-resumes-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/genenta-science-spa-adr-trading-resumes-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SPA","GNTA","BK4139"],"gpt_icon":0},{"id":"2474850093","title":"Genenta Science S.p.A.'s (NASDAQ:GNTA) market cap rose US$46m last week; individual investors who hold 55% profited and so did insiders","url":"https://stock-news.laohu8.com/highlight/detail?id=2474850093","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2474850093?lang=en_us&edition=full_marsco","pubTime":"2024-10-11 19:35","pubTimestamp":1728646528,"startTime":"0","endTime":"0","summary":"The considerable ownership by individual investors in Genenta Science indicates that they collectively have a greater say in management and business strategy. 45% of the business is held by the top 20 shareholders. Every investor in Genenta Science S.p.A.  should be aware of the most powerful shareholder groups. And the group that holds the biggest piece of the pie are individual investors with 55% ownership. Put another way, the group faces the maximum upside potential .Following a 57% increase in the stock price last week, individual investors profited the most, but insiders who own 28% stock also stood to gain from the increase.Let's take a closer look to see what the different types of shareholders can tell us about Genenta Science.Researching institutional ownership is a good way to gauge and filter a stock's expected performance. The same can be achieved by studying analyst sentiments. There is some analyst coverage of the stock, but it could still become more well known, with ti","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/fZxxC7WFAddugsI0.C6IZw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/2b615bb0216a492e754128412857f305","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/fZxxC7WFAddugsI0.C6IZw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/2b615bb0216a492e754128412857f305"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/genenta-science-p-nasdaq-gnta-113528751.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","IE00BGHQF748.EUR","MNQmain","PSQ","BK4585","BK4112","NQmain","LU2210150020.SGD","QID","SQQQ","BK4588","TQQQ","LU2210149790.SGD",".IXIC","IE00BKPKM429.USD","IE00B3QW5Z07.USD","QLD","NDAQ","GNTA","LU2095319765.USD","IE00B64PRP62.GBP"],"gpt_icon":1},{"id":"2473108576","title":"Analysts Offer Insights on Healthcare Companies: Danaher (DHR) and Genenta Science SpA Sponsored ADR (GNTA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2473108576","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2473108576?lang=en_us&edition=full_marsco","pubTime":"2024-10-07 21:10","pubTimestamp":1728306614,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Danaher (DHR – Research Report) and Genenta Science SpA Sponsored...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-danaher-dhr-and-genenta-science-spa-sponsored-adr-gnta?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-danaher-dhr-and-genenta-science-spa-sponsored-adr-gnta?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0289961442.SGD","LU0882574055.USD","LU1917777945.USD","LU0820561818.USD","IE00BZ1G4Q59.USD","LU2265009873.SGD","LU0109391861.USD","LU0289960550.SGD","GNTA","IE0004445239.USD","LU1267930730.SGD","LU1791710400.SGD","LU2125910179.SGD","SGXZ57979304.SGD","LU1551013425.SGD","LU0708995401.HKD","LU1804176565.USD","LU0820562030.AUD","IE00BKVL7J92.USD","LU0122379950.USD","LU2125910336.SGD","SG9999004303.SGD","SG9999013999.USD","BK4581","LU0097036916.USD","LU0943347566.SGD","LU1791710582.SGD","LU2063271972.USD","DHR","LU0289739343.SGD","LU0114720955.EUR","LU2112291526.USD","LU2125909593.SGD","SGXZ23171101.USD","LU1057294990.SGD","LU1923621640.USD","LU2023250504.SGD","LU0820561909.HKD","LU2355687059.USD","BK4137","BK4121","SG9999001176.SGD","HCSG","LU2211814178.USD","LU0320765059.SGD","LU1061106388.HKD","LU0511384066.AUD","LU1551013342.USD","LU2106854487.HKD","BK4588"],"gpt_icon":0},{"id":"2472052217","title":"Genenta Science Price Target Maintained With a $25.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2472052217","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2472052217?lang=en_us&edition=full_marsco","pubTime":"2024-10-02 22:51","pubTimestamp":1727880660,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/GNTA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  October 02, 2024 10:51 ET (14:51 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GNTA"],"gpt_icon":0},{"id":"2472546335","title":"Genenta Science Receives Regulatory Approval in Italy for Phase 1 Temferon Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2472546335","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2472546335?lang=en_us&edition=full_marsco","pubTime":"2024-10-02 19:05","pubTimestamp":1727867110,"startTime":"0","endTime":"0","summary":"Genenta Science  said Wednesday it received approval from the Italian Medicines Agency for a phase 1 clinical trial evaluating the company's drug Temferon in treating metastatic renal cell cancer.The trial is expected to commence in Q4, Genenta said. It will target patients with a median overall survival that is currently less than 2 years after multiple lines of therapy, the company added.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","GNTA"],"gpt_icon":0},{"id":"2472548029","title":"Genenta Secures Approval for Innovative Trial for Metastatic Renal Cell Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2472548029","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2472548029?lang=en_us&edition=full_marsco","pubTime":"2024-10-02 18:30","pubTimestamp":1727865000,"startTime":"0","endTime":"0","summary":"Glioblastoma study achieves milestone with successful dose escalation, setting stage for Phase 2MILAN and NEW YORK, Oct.  02, 2024  (GLOBE NEWSWIRE) -- Genenta Science (NASDAQ: GNTA), a pioneer in imm","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/10/02/2956792/0/en/Genenta-Secures-Approval-for-Innovative-Trial-for-Metastatic-Renal-Cell-Cancer.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GNTA"],"gpt_icon":0},{"id":"2471087918","title":"Genenta Science S.p.A. (GNTA): Early Investment Opportunity in Innovative Biotech","url":"https://stock-news.laohu8.com/highlight/detail?id=2471087918","media":"Insider Monkey","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2471087918?lang=en_us&edition=full_marsco","pubTime":"2024-09-30 17:12","pubTimestamp":1727687529,"startTime":"0","endTime":"0","summary":"We recently published a list of 10 Best Italian Stocks To Buy Now. In this article, we are going to take a look at where Genenta Science S.p.A.  stands against the other best Italian stocks to buy now.In 2023 and 2024, economic growth is expected to remain below 1%, signaling a shift in momentum after the initial recovery from the COVID-19 pandemic. The country has been heavily impacted by the euro area’s monetary tightening, which has increased borrowing costs for households, businesses, and the government. Lending rates for households and businesses have surged by around 3 percentage points since mid-2022. This has led to a slowdown in credit growth, which has turned negative, and a cooling of the housing market. While Italy’s banking sector remains well-capitalized and better prepared to absorb shocks compared to the past, the significant holdings of sovereign debt by banks and insurance companies pose potential risks, especially as economic growth continues to slow.The Italian gove","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/Gk62XAnlyr3ozq2rlHwDog--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/a0c37756e263a60a8576e6fc84255063","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/Gk62XAnlyr3ozq2rlHwDog--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/a0c37756e263a60a8576e6fc84255063"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/genenta-science-p-gnta-early-091209051.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["MNQmain","TQQQ","PSQ","SQQQ",".IXIC","QID","GNTA","BK4139","NQmain","QLD"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.genenta.com","stockEarnings":[{"period":"1week","weight":-0.0434},{"period":"1month","weight":0.0102},{"period":"3month","weight":-0.1865},{"period":"6month","weight":0.0122},{"period":"1year","weight":0.1343},{"period":"ytd","weight":-0.0874}],"compareEarnings":[{"period":"1week","weight":-0.0148},{"period":"1month","weight":-0.0654},{"period":"3month","weight":-0.0661},{"period":"6month","weight":-0.0277},{"period":"1year","weight":0.0623},{"period":"ytd","weight":-0.0519}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Genenta Science S.p.A., a clinical-stage biotechnology company, engages in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. Its lead product candidate is Temferon, which is in Phase 1/2a clinical trials for use in the treatment of glioblastoma multiforme in patients with unmethylated MGMT gene promoter. The company is developing Temferon for use in the treatment of other solid tumor indications, locally advanced hepatocellular carcinoma, and intra-hepatic cholangiocarcinoma. In addition, it develops biologic platform to deliver immunomodulatory molecules directly to the tumor by infiltrating monocytes/macrophages. Genenta Science S.p.A. was incorporated in 2014 and is headquartered in Milan, Italy.","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.123619},{"month":2,"riseRate":0.75,"avgChangeRate":0.010004},{"month":3,"riseRate":0.5,"avgChangeRate":-0.058717},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.082659},{"month":5,"riseRate":1,"avgChangeRate":0.158956},{"month":6,"riseRate":0,"avgChangeRate":-0.070801},{"month":7,"riseRate":0.333333,"avgChangeRate":0.081968},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.044246},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.055828},{"month":10,"riseRate":0.666667,"avgChangeRate":0.038265},{"month":11,"riseRate":0.666667,"avgChangeRate":0.059418},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.052188}],"exchange":"NASDAQ","name":"Genenta Science S.p.A.","nameEN":"Genenta Science S.p.A."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.32.1","shortVersion":"4.32.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Genenta Science S.p.A.(GNTA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Genenta Science S.p.A.(GNTA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Genenta Science S.p.A.,GNTA,Genenta Science S.p.A.股票,Genenta Science S.p.A.股票老虎,Genenta Science S.p.A.股票老虎国际,Genenta Science S.p.A.行情,Genenta Science S.p.A.股票行情,Genenta Science S.p.A.股价,Genenta Science S.p.A.股市,Genenta Science S.p.A.股票价格,Genenta Science S.p.A.股票交易,Genenta Science S.p.A.股票购买,Genenta Science S.p.A.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Genenta Science S.p.A.(GNTA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Genenta Science S.p.A.(GNTA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction